Sari Weinstein, MD
Dermatology · Oceanside, NYNPI 1932379690
Payments from drug & device makers
Across 32 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$130
- Galderma Laboratories, L.p.$79
- Novartis$68
- Glenmark Therapeutics Inc.$65
- Lilly USA, LLC$53
- Sun Pharmaceutical Industries Inc.$34
- plus $138 from 7 others
What the payments were for
- Food & beverage$567100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 6 | $130 |
| Galderma Laboratories, L.p. | 4 | $79 |
| Novartis | 3 | $68 |
| Glenmark Therapeutics Inc. | 8 | $65 |
| Lilly USA, LLC | 2 | $53 |
| Sun Pharmaceutical Industries Inc. | 2 | $34 |
| Merz North America, Inc. | 1 | $28 |
| LNHC, Inc | 1 | $21 |
| Pfizer | 1 | $21 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $19 |
| EPI Health, LLC | 1 | $17 |
| Organon | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
How this compares
$567 in reported general payments places this provider in the 30th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 119 | $1,983 |
| Betamethasone Dipropionate | 35 | $1,627 |
| Mupirocin | 167 | $1,171 |
| Clobetasol Propionate | 20 | $924 |
| Gentamicin Sulfate | 25 | $912 |
| Mometasone Furoate | 51 | $886 |
| Metronidazole | 15 | $853 |
| Econazole Nitrate | 19 | $534 |
| Clindamycin Phosphate | 13 | $478 |
| CiclopiroxCiclopirox Olamine | 19 | $398 |
| Ammonium Lactate | 20 | $384 |
| Triamcinolone Acetonide | 34 | $328 |
| Doxycycline Hyclate | 42 | $314 |
| ValacyclovirValacyclovir Hcl | 21 | $296 |
| Hydrocortisone | 45 | $200 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Oceanside
- Russell CohenOceanside$2.3M
- Emma GuttmanNew York$35.3M
- Saakshi KhattriNew York$15.4M
- James KruegerNew York$6.3M
- Michael CameronNew York$5.8M
- Mark LebwohlNew York$5.8M
- Andrew AlexisNew York$5.7M
- John TuRochester$5.4M
- Jeffrey WeinbergKew Gardens$4.9M
- Neil SadickNew York$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.